Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jan. 31, 2020
Jan. 31, 2019
Jan. 31, 2020
Jan. 31, 2019
Income Statement [Abstract]        
Revenue
Expenses:        
Research and development 6,055,218 4,746,530 11,485,031 9,485,975
General and administrative 7,468,375 3,733,408 11,886,660 6,497,497
Loss from operations (13,523,593) (8,479,938) (23,371,691) (15,983,472)
Other income, net 46,768 105,903 128,697 220,305
Interest expense (78) (1,070)
Foreign currency exchange (loss) gain, net (154,672) 63,912 (147,995) (108,002)
Realized loss on sale of securities, net (12,134)
Loss before income taxes (13,631,575) (8,310,123) (23,392,059) (15,883,303)
Provision for income taxes 2,450 4,904 2,450 7,340
Net loss $ (13,634,025) $ (8,315,027) $ (23,394,509) $ (15,890,643)
Basic and diluted net loss per common share $ (1.27) $ (1.33) $ (2.19) $ (2.7)
Weighted average shares used in computing basic and diluted net loss per common share 10,712,022 6,272,625 [1] 10,680,281 5,896,031 [1]
[1] On May 20, 2019, the Company effected a 1 for 10 reverse stock split. Shares have been retroactively restated.